Illumina (ILMN -1.2%) says its Board unanimously rejects Roche's (RHHBY.PK +2.3%) revised...

|By:, SA News Editor

Illumina (ILMN -1.2%) says its Board unanimously rejects Roche's (RHHBY.PK +2.3%) revised $51/share takeover offer, claiming the offer still undervalues ILMN and does not adequately reflect the company's singular position in an industry poised for extraordinary growth. (earlier)